Linical Co (TSE:2183) Total Stockholders Equity: 円3,976 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2183 Linical Co Ltd TSE:2183
40 GF Score
Price 円207.00
GF Value 円336.32
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co Total Stockholders Equity?

Linical Co TSE:2183 40 Total Stockholders Equity is 円3,976 Mil as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 40/100 and a GF Value™ of 円336.32 (Possible Value Trap). The stock has 5 warning signs investors should review.

Linical Co's Total Stockholders Equity for the quarter that ended in Mar. 2026 was 円3,976 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Linical Co's Book Value per Share for the quarter that ended in Mar. 2026 was 円176.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Linical Co's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.57.

Linical Co  (TSE:2183) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Linical Co's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(3976.192-0)/22.586
=176.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Linical Co's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1350.008 + 900.307) / 3976.192
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Total Stockholders Equity Related Terms

Linical Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Linical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Total Stockholders Equity Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,543.17 7,581.22 8,235.02 7,253.46 3,976.19

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,235.02 7,383.44 7,253.46 6,047.72 3,976.19
TSE:2183
40GF Score
Linical Co Ltd TSE:2183
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円3,976 Mil mean?
Linical Co (TSE:2183) has a Total Stockholders Equity of 円3,976 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Linical Co and its competitors.
Is Linical Co's Total Stockholders Equity too high?
Linical Co's current Total Stockholders Equity is 円3,976 Mil. Overall, Linical Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Total Stockholders Equity compare to VRTX and REGN?
Linical Co's Total Stockholders Equity of 円3,976 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Linical Co and its competitors. Linical Co's current Total Stockholders Equity is 円3,976 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円336.32, compared to a current price of 円207.00 — trading 38.5% below its estimated fair value. The current Total Stockholders Equity is 円3,976 Mil. Linical Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Total Stockholders Equity is 円3,976 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円207.00 is trading 38.5% below its estimated GF Value™ of 円336.32. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • Total Stockholders Equity: 円3,976 Mil
  • GF Value™: 円336.32 vs. price of 円207.00 (38.5% below fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
40GF Score

Get the complete analysis for TSE:2183

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円207.00
Price
円336.32
GF Value